JLJu Luo

Ju Luo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ju Luo has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Serum iron is associated with the prognosis in sepsis based on a large-scale database

    by Ju Luo, Ning Ding

    Studies on serum iron levels and prognosis in sepsis are limited. We conducted retrospective research based on a public database to investigate the relationships between the serum iron levels and clinical outcomes in sepsis. 2225 sepsis patients according to the Sepsis-3 criteria were enrolled in the study. Sepsis patients whose serum iron level was detected within 24 hours after admission were included. Univariate regression analysis was utilized to assess the relationships between different variables and patient prognosis including 28-day, 90-day, 180-day, and 1-year mortality rates. The relationship between serum iron levels and prognosis in three models were explored including model I: adjusted for none, model II: adjusted for age; gender, and model III: adjusted for potential confounders. Kaplan-Meier analysis for 1-year mortality rate among sepsis patients was performed. Age, anion gap, total bilirubin, ferritin, lactate, magnesium, phosphate, platelet, urea nitrogen, APSIII, and SOFA were associated with prognosis in sepsis. After adjusting for all potential confounders, for every 10-ug/dl increases in serum iron level, the ORs for 28-day, 90-day, 180-day, and 1-year mortality were 1.04, 1.06, 1.06, and 1.06, respectively. The Kaplan-Meier curves demonstrated a significantly lower survival probability in the highest serum iron level quartile than in the other quartiles. Higher serum iron levels were associated with increased 28-day, 90-day, 180-day, and 1-year mortality in sepsis.


  • Open Access

    Rhabdomyolysis Induced by Irbesartan‐Hydrochlorothiazide in an Elderly Patient

    by Wei Yang, Ju Luo, Wei Chen, Biao Peng

    A 90‐year‐old male with hypertension and diabetes presented with acute limb weakness and dizziness. Laboratory tests revealed severe hyponatremia (Na + 111.6 mmol/L) and rhabdomyolysis (CK 1771 U/L), which occurred after the recent initiation of irbesartan‐hydrochlorothiazide for edema. The patient's symptoms resolved, and the laboratory test results normalized after the drug was discontinued and the patient's sodium concentration was corrected with hypertonic saline. This case highlights hydrochlorothiazide‐induced hyponatremia as a rare trigger for rhabdomyolysis in elderly patients with comorbidities.


  • Open Access

    A cross-sectional analysis of coffee intake and hypertension prevalence: results from the NHANES 2005–2020

    by Hua Li, Wei Chen, Zao Zeng, Ning Ding, Ju Luo, Keng Li

    Objective: To investigate the association between coffee consumption and hypertension risk.Methods: Using data from the 2005–2020 National Health and Nutrition Examination Survey (NHANES) on 41,685 adults, multivariable logistic regression models examined the relationship between categorical coffee intake (none, >0 to < 1, ≥1 to < 2, ≥2 to < 3, ≥3 to < 4, and ≥4 cups/day) and hypertension, with stratified and curve-fitting analyses.Results: Compared to non-consumers, moderate daily intake of 1–3 cups was significantly associated with lower hypertension odds (OR 0.829–0.869, p < 0.05), more prominently in those < 60 years (OR 0.957, 95% CI 0.940–0.975). Curve fitting revealed a U-shaped association between coffee consumption and hypertension risk.Conclusion: While a moderate coffee intake (1–3 cups/day) was associated with a lower prevalence of hypertension, especially among adults under 60 years, this cross-sectional study cannot establish causality. Further prospective studies are needed to confirm these findings.


  • Open Access

    The Role of ADIPOQ and AMPK Signaling Pathway in Sarcopenia

    by Rihong Bin, Xinsheng Zheng, Ju Luo, Zhijie Liu, Haiyan Zhong, Feike Yang

    Objective: To identify the hub genes involved in sarcopenia and analyze their correlation with lipid metabolism. Methods: Differentially expressed genes (DEGs) from sarcopenia/non-sarcopenia cohorts in GSE111006 and GSE111010 datasets were cross-analyzed with diabetes-related genes (GeneCards). Key genes underwent functional enrichment and protein-protein interaction (PPI) network analysis. The expression and receiver operating characteristic (ROC) curve of the hub gene was analyzed in both datasets. Enzyme-linked immunosorbent assay (ELISA) was utilized to quantify hub gene levels in sarcopenia, type 2 diabetes (T2DM), and healthy samples. Results: Twenty key genes were identified through differential expression and diabetes-related gene screening. Functional enrichment analysis revealed their involvement in external stimulus response, inflammatory regulation, extracellular processes, adenosine monophosphate-activated protein kinase (AMPK) signaling pathway, and insulin signaling pathways (p< 0.05). Adiponectin (ADIPOQ) emerged as the hub gene via PPI network analysis, showing significant overexpression in sarcopenia (GSE111006: p< 0.01; GSE111010: p< 0.05) with diagnostic AUCs of 0.944 (0.869– 1.000) and 0.696 (0.471– 0.920) respectively. Ultimately, 60 sarcopenia, 10 type 2 diabetes, 10 healthy samples were collected. Seventy percent of the samples exhibited abnormal lipid metabolism. Adiponectin (ADIPOQ) and AMPK were overexpressed in sarcopenia samples (p < 0.01). However, ADIPOQ and AMPK were no difference in the expression levels between individuals with T2DM and healthy individuals (p> 0.05). This study identified a significant correlation between ADIPOQ, AMPK, and blood lipids in sarcopenia (ADIPOQ vs AMPK, p < 0.0001, r = 0.736; ADIPOQ vs HDL-C, p = 0.0003, r = − 0.448; AMPK vs HDL-C, p = 0.001, r = − 0.415). Conclusion: The present study confirms that glycolipid metabolism is a risk factor for sarcopenia. Both ADIPOQ and AMPK are overexpressed in sarcopenia and demonstrate a significant positive correlation. This study hypothesizes that ADIPOQ may regulate AMPK activity, affect lipid metabolism, and accelerate the occurrence and development of sarcopenia.


  • Serum Phosphate is a Biomarker for In-hospital and 30-day Mortality in Patients With Acute Pancreatitis Based on the MIMIC-IV Database

    by Kun Li, Shuo Cao, Kexiang Qin, Ju Luo, Ning Ding

    Background: Acute pancreatitis (AP) is the most common disease in emergency and intensive care units; early mortality predictions and intervention are crucial for improving patient prognosis. We investigated the association of serum phosphate with mortality among AP patients using a large public database. Methods: This was a retrospective study. All AP patients in the MIMIC-IV database were included. Based on the tertiles of serum phosphate, all AP patients were divided into 3 groups. Two generalized additive models were performed to explore the association of serum phosphate with in-hospital and 30-day mortality. Kaplan-Meier analysis was introduced for survival probability. Results: A total of 1088 AP patients admitted to the ICU were included. The mortalities of in-hospital (n=137) and 30-day (n=118) were 12.59% and 10.85%, respectively. The median levels of serum phosphate in the survivor and the non-survivor groups were 3.20 and 3.90 mg/dL, respectively (PP=0.0443) and 25% (HR=1.25, 95% CI: 1.03–1.52, P=0.0214), respectively. The areas under the ROC curve (AUC) of serum phosphate for predicting in-hospital and 30-day mortality were 0.650 (95% CI: 0.599–0.701) and 0.659 (95% CI: 0.605–0.714), respectively. The cutoff values of serum phosphate were 3.65 and 4.35 mg/dL, respectively. Conclusions: A linear positive relationship was found between serum phosphate and in-hospital and 30-day mortality in AP. Serum phosphate was associated with in-hospital and 30-day mortality in AP. Our results could be used for screening out those AP patients with a higher risk of worse outcomes.


  • Open Access

    A Machine Learning Method for Differentiation Crohn’s Disease and Intestinal Tuberculosis

    by Yufeng Shu, Zhe Chen, Jingshu Chi, Sha Cheng, Huan Li, Peng Liu, Ju Luo

    Background: Whether machine learning (ML) can assist in the diagnosis of Crohn’s disease (CD) and intestinal tuberculosis (ITB) remains to be explored. Methods: We collected clinical data from 241 patients, and 51 parameters were included. Six ML methods were tested, including logistic regression, decision tree, k-nearest neighbor, multinomial NB, multilayer perceptron, and XGBoost. SHAP and LIME were subsequently introduced as interpretability methods. The ML model was tested in a real-world clinical practice and compared with a multidisciplinary team (MDT) meeting. Results: XGBoost displays the best performance among the six ML models. The diagnostic AUROC and the accuracy of XGBoost were 0.946 and 0.884, respectively. The top three clinical features affecting our ML model’s result prediction were T-spot, pulmonary tuberculosis, and onset age. The ML model’s accuracy, sensitivity, and specificity in clinical practice were 0.860, 0.833, and 0.871, respectively. The agreement rate and kappa coefficient of the ML and MDT methods were 90.7% and 0.780, respectively (P< 0.001). Conclusion: We developed an ML model based on XGBoost. The ML model could provide effective and efficient differential diagnoses of ITB and CD with diagnostic bases. The ML model performs well in real-world clinical practice, and the agreement between the ML model and MDT is strong.


  • Open Access

    Association between admission hemoglobin level and prognosis in sepsis patients based on a critical care database

    by Hongchun Peng, Yingjie Su, Ju Luo, Ning Ding

    This study aimed to explore the association between admission hemoglobin level and clinical outcomes in sepsis based on Medical Information Mart for Intensive Care IV(MIMIC-IV) database. It was a retrospective study. Sepsis patients in the database were included. Data extraction from MIMIC-IV was performed by PostgreSQL 9.6 software. Three different models including crude model (adjusted for none), model I (adjusted for gender and age) and model II (adjusted for all potential cofounders) were constructed. A generalized liner model and a smooth fitting curve for indicating the relationship between hemoglobin level and 30-day mortality were performed. 6249 septic patients with a 30.18% of 30-day mortality were included. With 1 g/dl increment in hemoglobin level, the values of odds ratio (OR) in crude model, model I and model II were 0.96 (95% confidential interval (CI) 0.94–0.99, P = 0.0023), 0.96 (95%CI 0.93–0.98, P = 0.0010) and 0.87 (95%CI 0.79–0.95, P = 0.0020), respectively. The smooth fitting curve indicated a non-linear relationship and the turning point was 7.2 g/dl. Compared the hemoglobin group < 7.2 g/dl, the risk of 30-day mortality significantly decreased by 32% in the hemoglobin group ≥ 7.2 g/dl (OR = 0.68, 95%CI 0.51–0.93, P = 0.0142). The non-linear relationship between admission hemoglobin level and 30-day mortality in sepsis was found. Hemoglobin supplementation might be beneficial for septic patients with hemoglobin level < 7.2 g/dl.